Floatz logo

2-(P-(2-(P-CHLOROBENZAMIDO)ETHYL)PHENOXY)-2-METHYLPROPIONIC ACID

Hypercholesterolemia

SanofiSmall moleculePhase 4 / ApprovedDormant
BB
68/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
54/ 100
Competitive Position
89/ 100

Competitive context

10 Active assets in the Hypercholesterolemia cohort.

Asset / SponsorPhaseRating
Ezetimibe
Punjab Institute of Cardology
Phase 4BBB
Lipitor
Punjab Institute of Cardology
Phase 4BBB
SIMVASTATIN
paresh Dandona
Phase 4BBB
PITAVASTATIN
JW Pharmaceutical
Phase 4BBB
Rosuvastatin
Sanofi
Phase 4BB

View all 36 →

Same molecule, other indications

2-(P-(2-(P-CHLOROBENZAMIDO)ETHYL)PHENOXY)-2-METHYLPROPIONIC ACID is also rated in:

primary biliary cholangitisDormant
BB
Indicative ·
67 / 100
View asset →
acute coronary syndromeDormant
BB
Indicative ·
65 / 100
View asset →
Non Optimal Response to UDCADormant
B
Indicative ·
60 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →